EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
基本信息
- 批准号:6372298
- 负责人:
- 金额:$ 71.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-15 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:African American aging blood chemistry blood glucose blood lipid blood pressure body physical activity cardiovascular disorder cardiovascular disorder epidemiology caucasian American clinical research disease /disorder proneness /risk family genetics gender difference health behavior heart function human subject longitudinal human study nutrient intake activity obesity pathologic process racial /ethnic difference ultrasound blood flow measurement
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): The cardiovascular (C-V)
system is one of the organ systems most affected by the aging process.
Significant differences in C-V morbidity and mortality occur by race and gender
that influence longevity. The proposed research involves a biracial
(black-white) population that has been followed for C-V risk factors and
lifestyles in the Bogalusa Heart Study over the past 25 years. The specific aim
of the research is to characterize traits (intrinsic aging vs. The risk factor
burden) in a population reaching middle age that influence the subclinical C-V
disease process in normal aging. The extensive data base collected since
childhood provides information related to silent underlying C-V disease and
aging. The study cohort includes 1,200 individuals born between 1959 and 1969,
who were examined at least four times since childhood. The cohort will be
examined for: 1) C-V risk factor variables comprising obesity measures, blood
pressure, lipids, lipoproteins, apoliproproteins, homocysteine, glucose,
insulin, fibrinogen, plasminogen activator inhibitor 1, intercellular adhesion
molecules -1, C-reactive protein, lipid peroxides and microalbuminuria; 2)
lifestyle and psychosocial variables such as tobacco and alcohol use, physical
activity, diet, and life change events; 3) subclinical changes of the heart and
vasculature (outcome variables) observed by echo-Doppler measurements of
cardiac-carotid structure and function and brachial and radial artery
compliance; and 4) selected longevity-associated allele markers, like apoE.
These variables (except for the allele markers) will be measured at two points
in time, with a 3-year interval. In addition, a family history of longevity and
health history information on study subjects and their parents and grandparents
will be obtained to evaluate familial risk characteristics of the cohort. The
proposed studies will provide insights into the interaction of normal aging and
predisposing factors that influence the subclinical C-V disease process in a
black-white population reaching middle age. Understanding the evolution of C-V
risk in normal aging can lead to more rational programs for successful aging
and longevity and C-V disease prevention.
描述(改编自申请人摘要):心血管(C-V)
系统是受衰老过程影响最大的器官系统之一。
不同种族和性别的C-V发病率和死亡率存在显著差异
影响寿命的因素。拟议的研究涉及一项生物技术,
(黑人-白人)人群中的C-V风险因素,
在过去的25年里,博加卢萨心脏研究中的生活方式。具体目标
这项研究的目的是描述特征(内在衰老与风险因素
负担),影响亚临床C-V
正常衰老过程中的疾病。从那时起收集的大量数据库
儿童期提供了与无症状的潜在C-V疾病相关的信息,
衰老研究队列包括1959年至1969年出生的1,200人,
从童年起至少被检查过四次则将队列
检查:1)C-V风险因素变量,包括肥胖测量,血液
压力,脂质,脂蛋白,载脂蛋白,同型半胱氨酸,葡萄糖,
胰岛素,纤维蛋白原,纤溶酶原激活物抑制剂1,细胞间粘附
分子-1、C-反应蛋白、脂质过氧化物和微量白蛋白尿; 2)
生活方式和心理社会变量,如吸烟和饮酒,身体
活动、饮食和生活变化事件; 3)心脏的亚临床变化,
通过回声多普勒测量观察到的血管(结局变量)
心-颈动脉结构和功能以及肱动脉和桡动脉
依从性;和4)选择的长寿相关等位基因标记,如apoE。
这些变量(等位基因标记物除外)将在两个点进行测量
时间上,间隔3年。此外,家族长寿史和
研究受试者及其父母和祖父母的健康史信息
以评估队列的家族风险特征。的
拟议的研究将提供对正常衰老和
诱发因素,影响亚临床C-V疾病的过程中,
黑人白人达到中年。了解C-V的演变
正常衰老的风险可以导致更合理的成功衰老计划
以及预防心脑血管疾病的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD Sanders BERENSON其他文献
GERALD Sanders BERENSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD Sanders BERENSON', 18)}}的其他基金
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:
8436938 - 财政年份:2012
- 资助金额:
$ 71.34万 - 项目类别:
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:
8723711 - 财政年份:2012
- 资助金额:
$ 71.34万 - 项目类别:
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:
8548213 - 财政年份:2012
- 资助金额:
$ 71.34万 - 项目类别:
Evaluation of Cardiovascular Health Among Residents
居民心血管健康状况评价
- 批准号:
7044023 - 财政年份:2003
- 资助金额:
$ 71.34万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7119557 - 财政年份:2000
- 资助金额:
$ 71.34万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7288588 - 财政年份:2000
- 资助金额:
$ 71.34万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7918134 - 财政年份:2000
- 资助金额:
$ 71.34万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
6792730 - 财政年份:2000
- 资助金额:
$ 71.34万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
7489425 - 财政年份:2000
- 资助金额:
$ 71.34万 - 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:
6053741 - 财政年份:2000
- 资助金额:
$ 71.34万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 71.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




